| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A Brighton collaboration standardized template with key considerations for a benefit/risk assessment for a viral vector vaccine based on a non-replicating modified vaccinia virus Ankara viral vector
|
Link, Ellen K.
|
|
|
43 |
P1 |
p.
|
article
|
| 2 |
Assessment of the BNT162B2 COVID-19 vaccine immune response in Brazilian indigenous adolescents
|
de Oliveira, Laís Albuquerque
|
|
|
43 |
P1 |
p.
|
article
|
| 3 |
Australian parents' experiences with adolescent age-based vaccinations during the COVID-19 pandemic
|
Steffens, Maryke S.
|
|
|
43 |
P1 |
p.
|
article
|
| 4 |
Breakthroughs and insights: A comprehensive review of yellow fever vaccine breakthrough infection across 8 decades
|
Coulter, Felicity J.
|
|
|
43 |
P1 |
p.
|
article
|
| 5 |
Burden of Lassa fever disease in pregnant women and children and options for prevention
|
Chaudhary, Manu
|
|
|
43 |
P1 |
p.
|
article
|
| 6 |
Concurrent use of the foot-and-mouth disease and other vaccines in livestock
|
Göktuna, Pelin Tuncer
|
|
|
43 |
P1 |
p.
|
article
|
| 7 |
Corrigendum to “Evaluation of commercial quadrivalent foot-and-mouth disease vaccines against east African virus strains reveals limited immunogenicity and duration of protection” [Vaccine 42 (1–12) (2024) 126325]
|
Kerfua, Susan D.
|
|
|
43 |
P1 |
p.
|
article
|
| 8 |
Development of a candidate vaccine against severe fever with thrombocytopenia syndrome virus using Gn/Gc glycoprotein via multiple expression vectors delivered by attenuated Salmonella confers effective protection in hDC-SIGN transduced mice
|
Park, Ji-Young
|
|
|
43 |
P1 |
p.
|
article
|
| 9 |
Editorial Board
|
|
|
|
43 |
P1 |
p.
|
article
|
| 10 |
Herpes zoster vaccination among Medicare beneficiaries with and without prescription drug coverage
|
Tsai, Yuping
|
|
|
43 |
P1 |
p.
|
article
|
| 11 |
Immunogenicity of a classical swine fever bait vaccine (Flc-LOM- BErns) in hybrid-wild boars
|
Choe, SeEun
|
|
|
43 |
P1 |
p.
|
article
|
| 12 |
Improving the timeliness and equity of preschool childhood vaccinations: Mixed methods evaluation of a quality improvement programme in primary care
|
Marszalek, Milena
|
|
|
43 |
P1 |
p.
|
article
|
| 13 |
Intranasal immunization with CPAF combined with ADU-S100 induces an effector CD4 T cell response and reduces bacterial burden following intravaginal infection with Chlamydia muridarum
|
Poston, Taylor B.
|
|
|
43 |
P1 |
p.
|
article
|
| 14 |
Live-attenuated vaccine failure after liver transplantation: A 20-year cohort study
|
Furuichi, Munehiro
|
|
|
43 |
P1 |
p.
|
article
|
| 15 |
Modification and validation of a vaccine hesitancy scale for adolescent COVID-19 vaccination
|
Regan, Annette K.
|
|
|
43 |
P1 |
p.
|
article
|
| 16 |
Multisystem inflammatory syndrome in children (MIS-C) cases by vaccination status in California
|
Le Marchand, Chloe
|
|
|
43 |
P1 |
p.
|
article
|
| 17 |
Parental decisions regarding the vaccination of children and adolescents against SARS-CoV-2 from 2020 to 2023: A descriptive longitudinal study of parents and children in Montreal, Canada
|
Charland, Katia
|
|
|
43 |
P1 |
p.
|
article
|
| 18 |
Pertussis vaccination coverage in women at two months postpartum and associated factors in France, National Perinatal Survey 2021
|
Dilange, Lisa
|
|
|
43 |
P1 |
p.
|
article
|
| 19 |
Proteomic signatures of vaccine-induced and breakthrough infection-induced host responses to SARS-CoV-2
|
Williams, Erin
|
|
|
43 |
P1 |
p.
|
article
|
| 20 |
Randomized trial showing persistence of hSBA titers elicited by a pentavalent meningococcal MenABCWY vaccine for up to 4 years following a primary series and safety and immunogenicity of a booster dose
|
Peterson, James
|
|
|
43 |
P1 |
p.
|
article
|
| 21 |
Relative effectiveness of homologous NVX-CoV2373 and BNT162b2 COVID-19 vaccinations in South Korea
|
Gwak, Eunseon
|
|
|
43 |
P1 |
p.
|
article
|
| 22 |
Report of a SPEAC webinar 22 september 2023: Sensorineural hearing loss, lassa virus disease and vaccines
|
Reed, Nicholas S.
|
|
|
43 |
P1 |
p.
|
article
|
| 23 |
Safety and immunogenicity of the Ad26/protein preF RSV vaccine in adults aged 18 to 59 years with and without at-risk comorbidities for severe respiratory syncytial virus disease: A phase 3, randomized, controlled, immunobridging trial
|
Jastorff, Archana
|
|
|
43 |
P1 |
p.
|
article
|
| 24 |
Vaccination strategies to protect chickens from fowl adenovirus (FAdV)-induced diseases: A comprehensive review
|
De Luca, Carlotta
|
|
|
43 |
P1 |
p.
|
article
|
Journal description